z-logo
open-access-imgOpen Access
Role of Transvaginal Ultrasonography in the evaluation of Uterine Fibroids: a regional observation in Bangladesh
Author(s) -
Mukthadira,
MutaTah Hira,
Netay Kumer Sharma,
Asm Mahbubur Rahman,
Rong Ma,
Zakir Hossain,
MN Farzana,
Rubiat Naznin,
Maria Hossain
Publication year - 2018
Publication title -
community based medical journal
Language(s) - English
Resource type - Journals
eISSN - 2408-848X
pISSN - 2226-9290
DOI - 10.3329/cbmj.v7i2.55451
Subject(s) - uterine fibroids , medicine , transvaginal ultrasonography , leiomyoma , hysterectomy , gynecology , uterine leiomyoma , ultrasonography , obstetrics , radiology
Uterine fibroids, also known as leiomyomas, are the most common uterine neoplasms. Although benig, they can be associated with a significant number of morbidity and are the most common indication for hysterectomy. Transvaginal ultrasonography (TVS) has become essential in the diagnosis and management of the uterine fibroids. TVS provides a detailed examination of uterus and ovaries. However, there is no nation-wide and regional clinical study on the use of TVS for the evaluation of uterine fibroids in Bangladesh. In this work, a cross-sectional study toob serve the role of TVS in the evaluation of uterine fibroids in a region of Bangladesh (Greater Mymensingh). In the diagnosis of uterine fibroids by TVS, we observed that 35(81.4%) cases (out of 43) are fibroids and 8 (18.6%) cases are non-fibroids. In histopathological diagnosis, we found 36 (83.7%) cases are uterine fibroids, and 7 (16.3%) cases are without fibroids. In this study, TVS diagnosed uterine fibroids with a sensitivity of 94.4%, the specificity of 85.71%, the accuracy of 97.6%, the positive predictive value of 97.1% and negative predictive value of 75%. The results demonstrate that TVS has the potential to become a useful imaging tool for the evaluation of uterine fibroids. CBMJ 2018 July: Vol. 07 No. 02 P: 17-23

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here